Are you interested in a new treatment for PTSD?
Are you a veteran with PTSD?
If so, you may like to consider participating in a trial of a new treatment for PTSD – transcranial magnetic stimulation (TMS).
What is TMS?
TMS involves applying magnetic pulses to the head. Most people describe it as a fast, tapping sensation. Given repeatedly over time, TMS appears to work by changing the activity level of cells in the brain and improving the way they communicate with each other.
The aim of TMS treatment in PTSD is to improve the way different parts of the brain that are affected by PTSD communicate with each other, thereby reducing the symptoms of PTSD, and leading to improvements in memory and thinking.
TMS has been used safely and effectively for depression for more than 15 years. We want to know if it can help with the symptoms of PTSD.
What will participation involve?
If you are eligible for the trial, you will be randomly allocated to an active ‘real’ TMS or a placebo ‘fake’ TMS treatment group. Both groups attend for individual TBS daily, Monday to Friday, 15 minutes a day, for four weeks at the Monash Alfred Psychiatry Research Centre (MAPrc) in Prahran. Participation in the study also includes a number of clinical interviews and memory and thinking tasks.
How do I sign up?
If you are a veteran experiencing PTSD, and are interested in participating, or would just like more information, please contact Sally Herring at Phoenix Australia on: 03 8344 2120
Or register your interest via email.
Why is the trial important?
Posttraumatic stress disorder (PTSD) is a common and serious mental health problem that can have a profound impact on a person’s functioning and quality of life. Although we have effective treatments for PTSD, there are still many veterans who do not benefit from these approaches. New and innovative treatments are required.
What are the benefits?
We hope that the active TMS may help with symptoms of PTSD, as well as difficulties with memory and attention. As TMS is a new treatment for PTSD, all participants would be helping us better understand PTSD and how we can assist those people experiencing it.
Who is conducting the trial?
The study is being conducted by Phoenix Australia – Centre for Posttraumatic Mental Health, and the Monash Alfred Psychiatry Research Centre (MAPrc).